Stock-Based Compensation - Stock Option Activity (Details) - USD ($)		9 Months Ended		12 Months Ended
		Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021
Number of shares
Options granted		1,518,154	3,185,542
Options exercised		(429,955)
2016 Plan
Number of shares
Outstanding options at beginning of year		3,647,581
Options granted	[1]	1,518,154
Options exercised	[2]	(429,955)
Options expired and canceled		(22,542)
Outstanding options at end of quarter		4,713,238		3,647,581
Options exercisable at end of quarter		843,431
2006 Plan
Number of shares
Outstanding options at end of quarter		389,509
Weighted-average exercise price per option
Outstanding options at beginning of year		$ 1.09
Options granted	[1]	0.71
Options exercised	[2]	0.81
Options expired and canceled		4.19
Outstanding options at end of quarter		0.98		$ 1.09
Options exercisable at end of quarter		$ 2.67
Weighted-average remaining contractual term
Outstanding options		8 years 3 months 18 days		8 years 6 months
Options exercisable at end of quarter		5 years 4 months 24 days
Aggregate Intrinsic Value
Outstanding options at beginning of year		$ 810,596
Options exercised	[2]	2,211,896
Outstanding options at end of quarter		28,912,358		$ 810,596
Options exercisable at end of quarter		$ 3,748,935

[1] Primarily represents the grant of stock options to purchase an aggregate of 1,078,913 shares of the Company’s common stock, at an exercise price of $0.69 per share, in connection with the time-based grant of awards under its 2021-2023 LTIP, see Note 5, Long-Term Incentive Plans. In March 2021, the Company also granted to active participants of the LTIP a discretionary grant of stock options to purchase an aggregate of 414,337 shares of the Company’s common stock, at an exercise price of $0.75 per share, which will vest ratably over 3 years.

[2] As a result of net share settlement, of the 429,955 stock options exercised, only 298,150 shares of common stock were issued.